Pharma deal fever boosts flurry of highly complex mergers
🇬🇧 English
Aanu Adeoye Published September 25 2026 Jump to comments section Print this page Unlock the Editor's Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Deal fever has returned to the pharmaceutical industry as big drugmakers snap up smaller rivals to stave off a looming
🇸🇦 العربية
اندفاع الصفقات الصيدلانية يطفي طفيله من عمليات الدمج المعقدة للغاية
Aanu Adeoye Published September 25 2026 Jump to comments section Print this page Unlock the Editor's Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Deal fever has returned to the pharmaceutical industry as big drugmakers snap up smaller rivals to stave off a looming
لماذا تنتشر أوجاع الصفقات في صناعة الأدوية؟
انتشر أوجاع الصفقات في صناعة الأدوية لأن كبار صانعي الأدوية يشترون المنافسين الأصغر للتغلب على التحديات المتزايدة في السوق والضغط التنافسي.
🇧🇩 বাংলা
ফার্মাসিউটিক্যাল শিল্পে জোরপূর্ণ মিলের জ্বালা উচ্চ জটিলতার মিলের ঝড় চলছে
Aanu Adeoye Published September 25 2026 Jump to comments section Print this page Unlock the Editor's Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Deal fever has returned to the pharmaceutical industry as big drugmakers snap up smaller rivals to stave off a looming
ফার্মাসিউটিক্যাল শিল্পে জোরপূর্ণ মিলের জ্বালা কেন ঘটে?
ফার্মাসিউটিক্যাল শিল্পে জোরপূর্ণ মিলের জ্বালা ঘটে বড় ওষুধ নির্মাতরা বাড়ি যুক্ত প্রতিযোগীদের কিনে মার্কেটের বৃদ্ধমান চ্যালেঞ্জ ও প্রতিযোগিতার চাপের সম্মুখীন হয়।
🇩🇪 Deutsch
Die Fieberphase bei Pharma-Deal-Transaktionen löst eine Welle hochkomplexer Fusionen aus
Aanu Adeoye Published September 25 2026 Jump to comments section Print this page Unlock the Editor's Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Deal fever has returned to the pharmaceutical industry as big drugmakers snap up smaller rivals to stave off a looming
Warum gibt es in der Pharmaindustrie eine Fieberphase bei Deals?
In der Pharmaindustrie gibt es eine Fieberphase bei Deals, weil große Hersteller kleinere Rivale übernehmen, um zunehmende Markt-Herausforderungen und Wettbewerbsdruck zu meistern.
🇪🇸 Español
La fiebre de fusiones en el sector farmacéutico impulsa una ráfaga de fusiones altamente complejas
Aanu Adeoye Published September 25 2026 Jump to comments section Print this page Unlock the Editor's Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Deal fever has returned to the pharmaceutical industry as big drugmakers snap up smaller rivals to stave off a looming
¿Por qué surge la fiebre de fusiones en el sector farmacéutico?
La fiebre de fusiones en el sector farmacéutico se debe a que los grandes fabricantes de medicamentos adquieren rivales más pequeños para afrontar los crecientes desafíos del mercado y la presión competitiva.
🇫🇷 Français
La fièvre des accords pharmaceutiques relance une tempête de fusions hautement complexes
Aanu Adeoye Published September 25 2026 Jump to comments section Print this page Unlock the Editor's Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Deal fever has returned to the pharmaceutical industry as big drugmakers snap up smaller rivals to stave off a looming
Pourquoi la fièvre des accords pharmaceutiques existe-t-elle ?
La fièvre des accords pharmaceutiques existe parce que les grands fabricants de médicaments rachetent des rivaux plus petits pour faire face aux défis croissants du marché et à la pression concurrentielle.
🇮🇳 हिन्दी
फार्माकेशियल उद्योग में जोरदार पूँजीगत संलयन की धूम में उच्च जटिलता वाले पूँजीगत संलयनों की लहर चल रही है
Aanu Adeoye Published September 25 2026 Jump to comments section Print this page Unlock the Editor's Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Deal fever has returned to the pharmaceutical industry as big drugmakers snap up smaller rivals to stave off a looming
फार्माकेशियल उद्योग में जोरदार पूँजीगत संलयन क्यों होते हैं?
फार्माकेशियल उद्योग में जोरदार पूँजीगत संलयन तभी होते हैं जब बड़े दवा निर्माता बढ़ते मार्केट चुनौतियों और प्रतिस्पर्धा का सामना करने के लिए छोटे प्रतिस्पर्धियों को खरीदते हैं।
🇮🇩 Bahasa Indonesia
Panas pembelian farmasi memicu ombak gabungan yang sangat kompleks
Aanu Adeoye Published September 25 2026 Jump to comments section Print this page Unlock the Editor's Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Deal fever has returned to the pharmaceutical industry as big drugmakers snap up smaller rivals to stave off a looming
Mengapa terdapat panas pembelian di industri farmasi?
Panas pembelian di industri farmasi terjadi karena produsen obat besar membeli pesaing yang lebih kecil untuk menghadapi tantangan pasar yang meningkat dan tekanan kompetitif.
🇯🇵 日本語
製薬業界のデル購買熱が激動の高度複雑合併を引き起こす
Aanu Adeoye Published September 25 2026 Jump to comments section Print this page Unlock the Editor's Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Deal fever has returned to the pharmaceutical industry as big drugmakers snap up smaller rivals to stave off a looming
製薬業界でなぜデル購買熱が生じるのですか？
製薬業界でのデル購買熱は、大手製薬会社が小規模のライバルを買収し、ますます深刻な市場課題や競争圧力に対処するためです。
🇧🇷 Português
A febre de negócios farmacêuticos impulsiona uma tempestade de fusões altamente complexas
Aanu Adeoye Published September 25 2026 Jump to comments section Print this page Unlock the Editor's Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Deal fever has returned to the pharmaceutical industry as big drugmakers snap up smaller rivals to stave off a looming
Por que surge a febre de negócios na indústria farmacêutica?
A febre de negócios na indústria farmacêutica surge porque grandes fabricantes de medicamentos compram rivais menores para enfrentar os crescentes desafios do mercado e a pressão competitiva.
🇷🇺 Русский
Пылающий интерес к фармацевтическим сделкам поднимает бурю высокосложных слияний
Aanu Adeoye Published September 25 2026 Jump to comments section Print this page Unlock the Editor's Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Deal fever has returned to the pharmaceutical industry as big drugmakers snap up smaller rivals to stave off a looming
Почему во фармацевтической отрасли возникает пылающий интерес к сделкам?
Пылающий интерес к сделкам в фармацевтической отрасли возникает потому, что крупные производители лекарств выкупают меньших конкурентов, чтобы справиться с растущими рыночными вызовами и конкурентным давлением.
🇨🇳 简体中文
制药行业并购热潮掀起一阵高复杂度收购浪潮
Aanu Adeoye Published September 25 2026 Jump to comments section Print this page Unlock the Editor's Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Deal fever has returned to the pharmaceutical industry as big drugmakers snap up smaller rivals to stave off a looming
制药行业为何会出现并购热潮？
制药行业的并购热潮是因为大型制药公司需要通过收购 smaller rivals 来应对日益增长的市场挑战和竞争压力。